摘要
Abstract
Objective To explore the clinical efficacy of plasmin injection combined with hydroxyethyl starch in the treatment of progressive cerebral infarction (PCI). Methods 120 cases of PCI patients admitted to our hospital from January 2013 to August 2015 were selected and divided into observation group (60 cases) and control group (60 cases) according to the admission sequence. The control group was given sodium ozagrel combined with bayaspirin conventional therapy, the observation group was given plasmin injection combined with hydroxyethyl starch treatment. The CCS scores before and after treatment, clinical efficacy in two groups were compared. Results After treatment, the CCS scores in two groups decreased significantly, and the droop degree in observation group was more obvious, with statistical difference (P<0.05). The total effective rate in observation group was 95.0%, significantly higher than 83.3%in control group, the difference was statistical (P<0.05). Conclusions Plasmin injection combined with hydroxyethyl starch in treatment of progressive cerebral infarction can effectively improve patient's conditions, and has more positive influence on patients' prognosis, which can be reasonable used in clinic.关键词
脑梗死/纤溶酶/羟乙基淀粉/颈内动脉粥样硬化/临床疗效Key words
Cerebral infarction/Plasmin/Hydroxyethyl starch/Carotid atherosclerosis/Clinical efficacy分类
医药卫生
